Skip to main content
. Author manuscript; available in PMC: 2013 Sep 3.
Published in final edited form as: Cytotherapy. 2010 Sep 20;13(1):98–107. doi: 10.3109/14653249.2010.515582

Figure 3.

Figure 3

IL-15 levels increase after lymphodepleting therapy. Plasma was collected from patients at the indicated time-points before and after the Hi-Cy/Flu ± TBI preparative regimen. A significant increase in IL-15 concentration was detected following the chemotherapy prior to donor NK infusion and at day + 7. By day +14 concentrations began to decrease. Error bars represent standard error of the mean.